Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pranay Tanwar

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
JCO Global Oncology|July 11, 2025
Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North IndiaChitrakshi Nagpal, Mohit Kumar Divakar, Hemavathi Baskarane, et al.
Journal of Translational Medicine|December 2, 2025
Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4Ravi Chauhan, Gunjan Dagar, Lakshay Malhotra, et al.
Cancers|June 13, 2025
RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid LeukemiaHarsh Goel, Avanish Kumar Pandey, Rahul Kumar, et al.
Journal of Translational Medicine|April 29, 2023
Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progressionRavi Chauhan, Ashna Gupta, Lakshay Malhotra, et al.
Scientific Reports|August 12, 2024
Somatic mutational landscape across Indian breast cancer cases by whole exome sequencingRahul Kumar, Supriya Awasthi, Dibyabhaba Pradhan, et al.
Cancers|May 27, 2026
Integrated Genomic Profiling of Newly Diagnosed and Relapsed Acute Myeloid Leukemia Identifies Driver Genes, Mutational Signatures, and Therapeutic TargetsHarsh Goel, Avanish Kumar Pandey, Anshul Arya, et al.
International Journal of Cancer|June 8, 2026
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource SettingsNeerja Bhatla, MaryLuz Rol, Seema Singhal, et al.
Trials|February 26, 2025
A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)Adhip Arora, V Seenu, Rajinder Parshad, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
JCO Global Oncology|July 11, 2025
Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North IndiaChitrakshi Nagpal, Mohit Kumar Divakar, Hemavathi Baskarane, et al.
Journal of Translational Medicine|December 2, 2025
Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4Ravi Chauhan, Gunjan Dagar, Lakshay Malhotra, et al.
Cancers|June 13, 2025
RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid LeukemiaHarsh Goel, Avanish Kumar Pandey, Rahul Kumar, et al.
Journal of Translational Medicine|April 29, 2023
Ubiquitin specific peptidase 37 and PCNA interaction promotes osteosarcoma pathogenesis by modulating replication fork progressionRavi Chauhan, Ashna Gupta, Lakshay Malhotra, et al.
Scientific Reports|August 12, 2024
Somatic mutational landscape across Indian breast cancer cases by whole exome sequencingRahul Kumar, Supriya Awasthi, Dibyabhaba Pradhan, et al.
Cancers|May 27, 2026
Integrated Genomic Profiling of Newly Diagnosed and Relapsed Acute Myeloid Leukemia Identifies Driver Genes, Mutational Signatures, and Therapeutic TargetsHarsh Goel, Avanish Kumar Pandey, Anshul Arya, et al.
International Journal of Cancer|June 8, 2026
Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource SettingsNeerja Bhatla, MaryLuz Rol, Seema Singhal, et al.
Trials|February 26, 2025
A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)Adhip Arora, V Seenu, Rajinder Parshad, et al.
Pageof 12